Alnylam Pharmaceuticals
ALNY
$177.10
Share price
1.76%
Change (1 day)
-16.47%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Market capitalization of Alnylam Pharmaceuticals (ALNY)
Market cap: $22.13 Billion
As of October 2023 Alnylam Pharmaceuticals has a market cap of $22.13 Billion. This makes Alnylam Pharmaceuticals the world's 773th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Alnylam Pharmaceuticals from 2004 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $22.13 B | -24.28% |
| 2022 | $29.23 B | 44.16% |
| 2021 | $20.28 B | 34.32% |
| 2020 | $15.10 B | 16.87% |
| 2019 | $12.92 B | 75.15% |
| 2018 | $7.37 B | -41.45% |
| 2017 | $12.59 B | 292.16% |
| 2016 | $3.21 B | -59.89% |
| 2015 | $8.01 B | 6.97% |
| 2014 | $7.48 B | 82.71% |
| 2013 | $4.09 B | 327.85% |
| 2012 | $0.95 B | 175.09% |
| 2011 | $0.34 B | -16.59% |
| 2010 | $0.41 B | -43.36% |
| 2009 | $0.73 B | -28.02% |
| 2008 | $1.02 B | -13.62% |
| 2007 | $1.18 B | 49.54% |
| 2006 | $0.79 B | 207.77% |
| 2005 | $0.25 B | 78.85% |
| 2004 | $0.14 B |
End of Day market cap according to different sources
On Sep 30th, 2023 the market cap of Alnylam Pharmaceuticals was reported to be:
$22.13 Billion
$22.13 Billion
$22.13 Billion
$22.13 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $210.67 B | 851.65% | 🇨🇭 Switzerland |
 Sanofi SNY | $136.32 B | 515.80% | 🇫🇷 France |
 Regeneron Pharmaceuticals REGN | $89.33 B | 303.56% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $11.30 B | -48.92% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $26.69 M | -99.88% | 🇺🇸 USA |
 OPKO Health
OPK | $1.23 B | -94.41% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $11.43 B | -48.36% | 🇮🇱 Israel |
 Arrowhead Pharmaceuticals
ARWR | $2.88 B | -86.99% | 🇺🇸 USA |